Description of Microbiological Analysis:

Vancomycin-resistant Enterococci (VRE) are strains of the genus Enterococcus (most commonly E. faecium and E. faecalis) that have acquired resistance to vancomycin, an antibiotic often reserved for the most serious Gram-positive infections. These bacteria are opportunistic pathogens that frequently colonize the gastrointestinal tract. Resistance is usually mediated by the vanA or vanB gene clusters, which alter the cell wall precursors, preventing the antibiotic from binding. Detecting VRE is a vital clinical and epidemiological task, as these pathogens can cause life-threatening infections in immunocompromised patients and are highly resilient in the hospital environment.

What does the analysis represent?

• Purpose: To isolate Enterococcus species from a clinical sample and confirm their ability to grow in the presence of specific concentrations of vancomycin.
• Main Application: Active surveillance and screening of high-risk patients (e.g., those in ICU, oncology, or transplant units), diagnosis of complex urinary tract infections, endocarditis, or bacteremia, and monitoring hospital infection control effectiveness.
• Method: Microbiological culture using selective enrichment broths or agar media supplemented with vancomycin, followed by confirmatory species identification and susceptibility testing.

Recommendations for the Test (General)

• Time: Specimens (rectal swabs, stool, urine, or blood) should be collected based on clinical indications or institutional screening protocols upon hospital admission.
• Fasting: Dietary restrictions are not required for VRE culture testing.
• Rest: No physical rest is necessary; however, strict adherence to aseptic collection techniques is required to maintain sample integrity.
• Specific Rules: The specimen must be obtained prior to the administration of glycopeptide or lipopeptide antibiotics. If the patient is already receiving antimicrobial therapy, the clinical team must inform the laboratory to adjust the interpretation of the results.

What can affect the results?

• Factors altering levels: Current use of antibiotics to which the VRE strain might be susceptible (though rare); use of rectal suppositories, medicated enemas, or topical ointments at the collection site within 24 hours; contamination of stool samples with urine or water; and significant delays in transporting the specimen to the lab without proper transport media.

When to take the test?

• Recommendations: The test is indicated for patients with a history of long-term hospitalization, those undergoing hemodialysis, organ transplant recipients, or individuals with chronic infections that do not respond to conventional therapy.
• Preparation: For rectal swabs—the gold standard for colonization screening—no specific preparation is needed, but the procedure should be performed by a trained healthcare professional. For urine samples, mid-stream collection after thorough hygiene is essential.

How to interpret the results?

The interpretation of the obtained data is the exclusive responsibility of the physician. In accordance with healthcare regulations and legal mandates for the surveillance of multi-drug resistant organisms (MDROs), a “Detected” result for VRE indicates that the patient is a carrier or is actively infected. This result necessitates immediate implementation of contact precautions and a mandatory shift in the therapeutic strategy toward alternative antibiotics like linezolid or daptomycin. Only professional medical analysis can differentiate between harmless colonization and a disease-state infection based on the patient’s clinical presentation and the site of isolation.

Possible further investigations

• Minimum Inhibitory Concentration (MIC) testing: To determine the sensitivity levels for alternative antimicrobial agents.
• Molecular Genotyping (PCR for vanA/vanB genes): To identify the specific genetic cluster and assess the risk of resistance transfer to other bacteria.
• Ultrasound or CT Imaging: If the infection is localized in the urinary tract or abdomen to check for structural complications.
• Infectious Disease Consultation: To establish a long-term management and isolation plan.

When does the next step make sense?

If the VRE culture is positive, the next step involves the immediate selection of advanced antimicrobial therapy and the enforcement of strict hygiene measures to prevent transmission to other vulnerable patients. All follow-up diagnostic and therapeutic actions must be conducted under rigorous medical oversight to ensure the safety of both the patient and the healthcare facility.

👉 If necessary, you can discuss the results of the analysis with a specialist, such as an gastroenterologist (Doctors – TAMC).